SCHEMBL7578803

SCHEMBL7578803

O=S(=O)(Nc1ccccc1F)c1cccs1

nearest known ligand 0.73

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.73
CCR2 P41597 4/20 0.64
ALDH1A1 P00352 2/20 0.61
NPC1 O15118 1/20 0.61
MEN1 O00255 4/20 0.58
KMT2A Q03164 4/20 0.58
MAPT P10636 1/20 0.58
BRAF P15056 1/20 0.56
HKDC1 Q2TB90 1/20 0.56
PKM P14618 2/20 0.56
GAA P10253 1/20 0.56
MCOLN3 Q8TDD5 1/20 0.56
NFKBIA P25963 1/20 0.54
RELA Q04206 1/20 0.54
GLO1 Q04760 1/20 0.54
KDM4E B2RXH2 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7594332 0.88 ALDH1A1 (0.71) TP53ALDH1A1NPC1MEN1KMT2A
SCHEMBL7590993 0.85 CCR2 (0.66) TP53CCR2ALDH1A1NPC1MEN1
SCHEMBL15009888 0.80 ALDH1A1 (0.61) TP53ALDH1A1NPC1MEN1KMT2A
SCHEMBL10878905 0.80 ALDH1A1 (0.61) TP53ALDH1A1NPC1MEN1KMT2A
SCHEMBL7569883 0.80 PKM (0.79) TP53CCR2ALDH1A1NPC1MEN1
SCHEMBL7578741 0.80 BRAF (0.68) TP53ALDH1A1NPC1MEN1KMT2A
SCHEMBL9931016 0.79 CCR2 (1.00) TP53CCR2MEN1KMT2AMAPT
SCHEMBL7573015 0.78 CCR2 (0.64) TP53CCR2ALDH1A1NPC1MEN1
SCHEMBL7571210 0.78 CCR2 (0.67) TP53CCR2ALDH1A1NPC1MEN1
SCHEMBL463967 0.78 ALDH1A1 (0.58) TP53CCR2ALDH1A1NPC1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1239852-A2 BISSULFONAMIDE DERIVATIVES AS ENZYME INHIBITORS Arrow Therapeutics Limited (GB) 2002-09-18 EP disclosed
WO-2001028537-A2 BISSULFONAMIDE DERIVATIVES AS ENZYME INHIBITORS ARROW THERAPEUTICS LIMITED (GB) 2001-04-26 WO disclosed